Scientific Advisory Panel on Anti-Infective Therapies (SAP-AIT)
October 6, 2016
Agenda
Place: Room 2048, 2nd floor, Tower B, Holland Cross 1600 Scott Street Ottawa
Date and Time: October 6th, 2016, 9:00am to 4:00pm, EST
Chairperson: Gerald A. Evans
Science Advisor: Conrad Pereira
Science and Regulatory Officers: Osama Wahid, Shelley Wagner
Participants: SAP-AIT, Health Canada
| Number | Time | Description |
|---|---|---|
| 1. | 09:00-09:05Footnote * (5 min) |
Welcome and Opening remarks Marion Law, Director General, Therapeutic Products Directorate |
| 2. | 09:05-09:15 (10 min) (10 min) |
Introduction of Members, Review of Mandate, Associations/Affiliations and Agenda Chair - Gerald A. Evans |
| 3. | 09:15-10:00 (45 min) |
Health Canada Presentation on the Safety of Fluoroquinolones Melissa Hunt, Manager, Marketed Pharmaceuticals and Medical Devices Bureau Questions from Panel members |
| 4. | 10:00-10:15 (15 min) |
Health break |
| 5. | 10:15-11:00 (45 min) |
Health Canada Presentation on the Efficacy of Fluoroquinolones for Specific Indications, and Introduction of Questions for the Panel Philippa McDonald, Clinical Evaluator, Therapeutic Products Directorate Questions from Panel members |
| 6. | 11:00-12:00 (60 min) |
Lunch (Panel) |
| 7. | 12:00- 03:00 (180 min) |
Deliberation on Health Canada's Questions Panel members |
| 8. | 03:00-03:15 (15 min) |
Summary of Recommendations Chair |
| 9. | 03:15-03:20 (5 min) |
Closing Remarks and Adjournment of Meeting Chair |
|
||